LCP1 and renal cell carcinoma: To evaluate their potential as tumor markers for RCC, serum concentrations of three tumor markers, NNMT, LCP1, and NM23A, were assayed with a total of 1042 specimens from 500 control healthy subjects and 542 patients with RCC of pathological stages I–IV.